Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation
- 1 October 1982
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 38 (1) , 136-140
- https://doi.org/10.1128/iai.38.1.136-140.1982
Abstract
The immunogenicity of 2 temperature-sensitive (ts) mutants of P. aeruginosa immunotype 1, isolated and characterized for the development of a safe, live vaccine strain, was evaluated in a mouse protection model. One mutant, A/10/25, had a limited coasting property (i.e., continued replication for 2 divisions) at the nonpermissive temperature (36.degree. C); the other mutant, E/9/9, continued replication for 5 generations after transfer to 36.degree. C. Groups of 3-5 wk old ICR mice were immunized i.p. with various doses of the 2 ts mutants; at various times thereafter, the mice were challenged i.p. with lethal doses of the parental wild type. The more extensive coaster, E/9/9, induced 100% protection at immunizing doses lower than those required for A/10/25 to induce the same protection (1-2 .times. 108 and 6 .times. 108 colony-forming units, respectively). Both ts strains induced significant protection for up to 5 wk after immunization. Evidently, the use of P. aeruginosa ts mutants might provide a novel approach to the prevention of P. aeruginosa colonization of the lungs patients with cystic fibrosis.This publication has 25 references indexed in Scilit:
- Active Immunization with Lipopolysaccharide Pseudomonas Antigen for Chronic Pseudomonas Bronchopneumonia in Guinea PigsJournal of Clinical Investigation, 1981
- Isolation and characterization of a Pseudomonas aeruginosa mutant producing a nontoxic, immunologically crossreactive toxin A protein.Proceedings of the National Academy of Sciences, 1980
- INHIBITORY EFFECT OF CYSTIC FIBROSIS SERUM ON PSEUDOMONAS PHAGOCYTOSIS BY RABBIT AND HUMAN ALVEOLAR MACROPHAGESPediatric Research, 1979
- Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitroJournal of Antimicrobial Chemotherapy, 1978
- Temperature-Sensitive Mutants of Type I Streptococcus pneumoniae: Preparation, Characterization, and Evidence for Attenuation and ImmunogenicityThe Journal of Infectious Diseases, 1977
- A New Polyvalent Pseudomonas VaccineJournal of Medical Microbiology, 1977
- Use of a Pseudomonas aeruginosa vaccine in patients with acute leukemia and cystic fibrosisThe American Journal of Medicine, 1975
- Isolation and Characterization of Antigenic Components of a New Heptavalent Pseudomonas VaccineNature New Biology, 1971
- MUCOID PSEUDOMONAS qRUGINOSA IN PATIENTS WITH CHRONIC ILLNESSESThe Lancet, 1971
- Prevention of Invasive Pseudomonas Infection in Burns With a New VaccineArchives of Surgery, 1969